Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KMB vs GSK✓SelectedUSD · GSKKMB vs GSK performance historyLatest closeAs of-0.84%11/18
Stock and ETF performance explorer

KMB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+34.7%
GSK return
+100.8%
Excess return
-66.1%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-1.3%+0.5%-0.4%
7D-1.5%-3.1%+1.6%-0.5%
30D+1.7%-0.9%+2.6%+2.1%
3M+0.7%-4.2%+4.9%+2.0%
6M+14.0%-1.6%+15.6%+14.3%
YTD+10.4%+2.6%+7.8%+9.0%
1Y+9.2%+6.2%+3.0%+6.6%
3Y+0.1%+55.0%-54.8%-14.9%
5Y-2.0%+42.8%-44.9%-16.0%
All+34.7%+100.8%-66.1%+0.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling